Pancreatic cancer is expected to become the second leading cause of the cancer related deaths in the USA by 2020. The goal of all pre-clinical magnetic resonance imaging (MRI) studies is to translate the pre-clinical MR values to the clinical scanners and ultimately to human population. MRI has been proven to be extremely useful in clinical trials for monitoring tumor development and assessing therapeutic effects of novel therapeutic strategies. The aim of this study was to measure (T2) relaxation time and magnetization ratio (MTR) in a mouse model of pancreatic ductal adenocarcinoma (PDA) at pre-clinical (14T) and clinical (3T) scanner.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords